Richard L. Love, Director at CELL THERAPEUTICS INC (CTIC), sold 61,900 shares at $0.37 ($22K) on 2010-05-24, disclosed to the SEC on 2010-05-26.
Scheduled sale ($22k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.33 | 300 | $99 | 0.5% |
| 2 | $0.34 | 500 | $170 | 0.8% |
| 3 | $0.34 | 1,100 | $374 | 1.7% |
| 4 | $0.34 | 1,700 | $578 | 2.7% |
| 5 | $0.34 | 5,300 | $2K | 8.3% |
| 6 | $0.34 | 7,900 |
| $3K |
| 12.4% |
| 7 | $0.34 | 4,400 | $1K | 6.9% |
| 8 | $0.34 | 5,600 | $2K | 8.8% |
| 9 | $0.34 | 2,362 | $803 | 3.7% |
| 10 | $0.35 | 4,300 | $2K | 7.0% |
| 11 | $0.35 | 2,291 | $802 | 3.7% |
| 12 | $0.35 | 2,300 | $805 | 3.7% |
| 13 | $0.35 | 1,200 | $420 | 1.9% |
| 14 | $0.35 | 300 | $105 | 0.5% |
| 15 | $0.35 | 2,100 | $735 | 3.4% |
| 16 | $0.35 | 1,400 | $490 | 2.3% |
| 17 | $0.36 | 1,800 | $648 | 3.0% |
| 18 | $0.36 | 800 | $288 | 1.3% |
| 19 | $0.36 | 1,300 | $468 | 2.2% |
| 20 | $0.36 | 1,347 | $485 | 2.2% |
| 21 | $0.36 | 1,700 | $612 | 2.8% |
| 22 | $0.36 | 2,000 | $720 | 3.3% |
| 23 | $0.36 | 2,400 | $864 | 4.0% |
| 24 | $0.36 | 2,600 | $936 | 4.3% |
| 25 | $0.36 | 2,700 | $972 | 4.5% |
| 26 | $0.37 | 100 | $37 | 0.2% |
| 27 | $0.37 | 1,300 | $481 | 2.2% |
| 28 | $0.37 | 800 | $296 | 1.4% |
| Total | $0.35 avg | 61,900 | $22K | 100% |
| Filing → |
| PRXL | SELL | 2015-12-02 | $91K | — | Filing → |
| CTIC | SELL | 2015-10-01 | $20K | — | Filing → |
| PRXL | SELL | 2015-09-03 | $85K | — | Filing → |